PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Nephrology, Stanford University, Palo Alto, CA, USA. Electronic address: sanand2@stanford.edu.\', \'Division of Nephrology, Stanford University, Palo Alto, CA, USA.\', \'Ascend Clinical Laboratory, Redwood City, CA, USA.\', \'Division of Infectious Diseases & Geographic Medicine, Stanford University, Palo Alto, CA, USA; Department of Medicine, and Department of Epidemiology and Population Health, Stanford University, Palo Alto, CA, USA.\', \'Division of Nephrology, Stanford University, Palo Alto, CA, USA; Department of Medicine, and Department of Epidemiology and Population Health, Stanford University, Palo Alto, CA, USA.\']
?:citedBy
  • -1
?:creator
?:doi
  • S0140-6736(20)32009-210.1016/S0140-6736(20)32009-2
?:doi
?:hasPublicationType
?:journal
  • Lancet (London, England)
is ?:pmid of
?:pmid
?:pmid
  • 32987007
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • Prevalence of SARS-CoV-2 antibodies in a large nationwide sample of patients on dialysis in the USA: a cross-sectional study.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all